This resistance is mainly associated with DNA repair systems like O6-methylguanine-DNA methyltransferase (MGMT)166 and mismatch repair in GBM cells, high GBM cell autophagy rates,165 and glioma stem cell phenotypic heterogeneity. The gene discussed is MGMT; the disease is central nervous system cancer.